United States Stem cell based Cell therapies-Drug Industry 2016 Deep Market Research Report
- QYR605651
- 135 Pages
- June 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Stem cell based Cell therapies-Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Stem cell based Cell therapies-Drug industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 145 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Definition and Specifications of Stem cell based Cell therapies-Drug
1.1.1 Definition of Stem cell based Cell therapies-Drug
1.1.2 Specifications of Stem cell based Cell therapies-Drug
1.2 Classification of Stem cell based Cell therapies-Drug
1.3 Applications of Stem cell based Cell therapies-Drug
1.4 Industry Chain Structure of Stem cell based Cell therapies-Drug
1.5 Industry Overview of Stem cell based Cell therapies-Drug
1.6 Industry Policy Analysis of Stem cell based Cell therapies-Drug
1.7 Industry News Analysis of Stem cell based Cell therapies-Drug
2 Manufacturing Cost Structure Analysis of Stem cell based Cell therapies-Drug
2.1 Bill of Materials (BOM) of Stem cell based Cell therapies-Drug
2.2 BOM Price Analysis of Stem cell based Cell therapies-Drug
2.3 Labor Cost Analysis of Stem cell based Cell therapies-Drug
2.4 Depreciation Cost Analysis of Stem cell based Cell therapies-Drug
2.5 Manufacturing Cost Structure Analysis of Stem cell based Cell therapies-Drug
2.6 Manufacturing Process Analysis of Stem cell based Cell therapies-Drug
2.7 United States Price, Cost and Gross of Stem cell based Cell therapies-Drug 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Stem cell based Cell therapies-Drug Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Stem cell based Cell therapies-Drug Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Stem cell based Cell therapies-Drug Key Manufacturers in 2015
4 Production Analysis of Stem cell based Cell therapies-Drug by Regions, Type, and Applications
4.1 United States Production of Stem cell based Cell therapies-Drug by Regions 2011-2016
4.2 United States Production of Stem cell based Cell therapies-Drug by Type 2011-2016
4.3 United States Sales of Stem cell based Cell therapies-Drug by Applications 2011-2016
4.4 Price Analysis of United States Stem cell based Cell therapies-Drug Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Stem cell based Cell therapies-Drug 2011-2016
5 Consumption Volume and Consumption Value Analysis of Stem cell based Cell therapies-Drug by Regions
5.1 United States Consumption Volume of Stem cell based Cell therapies-Drug by Regions 2011-2016
5.2 United States Consumption Value of Stem cell based Cell therapies-Drug by Regions 2011-2016
5.3 United States Consumption Price Analysis of Stem cell based Cell therapies-Drug by Regions 2011-2016
6 Analysis of Stem cell based Cell therapies-Drug Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Stem cell based Cell therapies-Drug 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Stem cell based Cell therapies-Drug 2014-2015
6.3 Sales Overview of Stem cell based Cell therapies-Drug 2011-2016
6.4 Supply, Consumption and Gap of Stem cell based Cell therapies-Drug 2011-2016
6.5 Import, Export and Consumption of Stem cell based Cell therapies-Drug 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Stem cell based Cell therapies-Drug 2011-2016
7 Analysis of Stem cell based Cell therapies-Drug Industry Key Manufacturers
7.1 CESCA Therapeutics Inc
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information
7.2 OCAtA Therapeutics Inc
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information
7.3 Orgenesis
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information
7.4 TiGenix NV
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information
7.5 Mesobalst Ltd
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information
7.6 Pluristem Therapeutics Inc
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.2.1 Type I
7.6.2.2 Type II
7.6.2.3 Type III
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
7.6.4 Contact Information
…
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Stem cell based Cell therapies-Drug Product Types
8.5 Market Share Analysis of Different Stem cell based Cell therapies-Drug Price Levels
8.6 Gross Margin Analysis of Different Stem cell based Cell therapies-Drug Applications
9 Marketing Trader or Distributor Analysis of Stem cell based Cell therapies-Drug
9.1 Marketing Channels Status of Stem cell based Cell therapies-Drug
9.2 Traders or Distributors of Stem cell based Cell therapies-Drug with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Stem cell based Cell therapies-Drug
9.4 United States Import, Export and Trade Analysis of Stem cell based Cell therapies-Drug
10 Development Trend of Stem cell based Cell therapies-Drug Industry 2016-2021
10.1 Capacity and Production Overview of Stem cell based Cell therapies-Drug 2016-2021
10.2 Production Market Share by Product Types of Stem cell based Cell therapies-Drug 2016-2021
10.3 Sales and Sales Revenue Overview of Stem cell based Cell therapies-Drug 2016-2021
10.4 United States Sales of Stem cell based Cell therapies-Drug by Applications 2016-2021
10.5 Import, Export and Consumption of Stem cell based Cell therapies-Drug 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Stem cell based Cell therapies-Drug 2016-2021
11 Industry Chain Suppliers of Stem cell based Cell therapies-Drug with Contact Information
11.1 Major Raw Materials Suppliers of Stem cell based Cell therapies-Drug with Contact Information
11.2 Manufacturing Equipment Suppliers of Stem cell based Cell therapies-Drug with Contact Information
11.3 Major Players of Stem cell based Cell therapies-Drug with Contact Information
11.4 Key Consumers of Stem cell based Cell therapies-Drug with Contact Information
11.5 Supply Chain Relationship Analysis of Stem cell based Cell therapies-Drug
12 New Project Investment Feasibility Analysis of Stem cell based Cell therapies-Drug
12.1 New Project SWOT Analysis of Stem cell based Cell therapies-Drug
12.2 New Project Investment Feasibility Analysis of Stem cell based Cell therapies-Drug
13 Conclusion of the United States Stem cell based Cell therapies-Drug Industry 2016 Market Research Report
Figure Picture of Stem cell based Cell therapies-Drug
Table Product Specifications of Stem cell based Cell therapies-Drug
Table Classification of Stem cell based Cell therapies-Drug
Figure United States Sales Market Share of Stem cell based Cell therapies-Drug by Product Types in 2015
Table Applications of Stem cell based Cell therapies-Drug
Figure United States Sales Market Share of Stem cell based Cell therapies-Drug by Applications in 2015
Figure Industry Chain Structure of Stem cell based Cell therapies-Drug
Table United States Industry Overview of Stem cell based Cell therapies-Drug
Table Industry Policy of Stem cell based Cell therapies-Drug
Table Industry News List of Stem cell based Cell therapies-Drug
Table Bill of Materials (BOM) of Stem cell based Cell therapies-Drug
Table Bill of Materials (BOM) Price of Stem cell based Cell therapies-Drug
Table Labor Cost of Stem cell based Cell therapies-Drug
Table Depreciation Cost of Stem cell based Cell therapies-Drug
Table Manufacturing Cost Structure Analysis of Stem cell based Cell therapies-Drug in 2015
Figure Manufacturing Process Analysis of Stem cell based Cell therapies-Drug
Table United States Price Analysis of Stem cell based Cell therapies-Drug 2011-2016 (USD/Unit)
Table United States Cost Analysis of Stem cell based Cell therapies-Drug 2011-2016 (USD/Unit)
Table United States Gross Analysis of Stem cell based Cell therapies-Drug 2011-2016
Table Capacity (Unit) and Commercial Production Date of United States Stem cell based Cell therapies-Drug Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Stem cell based Cell therapies-Drug Manufacturers in 2015
Table R&D Status and Technology Source of United States Stem cell based Cell therapies-Drug Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Stem cell based Cell therapies-Drug Key Manufacturers in 2015
Table United States Production of Stem cell based Cell therapies-Drug by Regions 2011-2016 (Unit)
Table United States Production Market Share of Stem cell based Cell therapies-Drug by Regions 2011-2016
Figure United States Production Market Share of Stem cell based Cell therapies-Drug by Regions in 2014
Figure United States Production Market Share of Stem cell based Cell therapies-Drug by Regions in 2015
Table United States Production of Stem cell based Cell therapies-Drug by Types in 2011-2016 (Unit)
Table United States Production Market Share of Stem cell based Cell therapies-Drug by Type in 2011-2016
Figure United States Production Market Share of Stem cell based Cell therapies-Drug by Type in 2014
Figure United States Production Market Share of Stem cell based Cell therapies-Drug by Type in 2015
Table United States Sales of Stem cell based Cell therapies-Drug by Applications 2011-2016 (Unit)
Table United States Production Market Share of Stem cell based Cell therapies-Drug by Applications 2011-2016
Figure United States Production Market Share of Stem cell based Cell therapies-Drug by Applications in 2014
Figure United States Production Market Share of Stem cell based Cell therapies-Drug by Applications in 2015
Table Price Comparison of United States Stem cell based Cell therapies-Drug Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Stem cell based Cell therapies-Drug 2011-2016
Table United States Consumption Volume of Stem cell based Cell therapies-Drug by Regions 2011-2016 (Unit)
Table United States Consumption Volume Market Share of Stem cell based Cell therapies-Drug by Regions 2011-2016
Figure United States Consumption Volume Market Share of Stem cell based Cell therapies-Drug by Regions in 2014
Figure United States Consumption Volume Market Share of Stem cell based Cell therapies-Drug by Regions in 2015
Table United States Consumption Value of Stem cell based Cell therapies-Drug by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Stem cell based Cell therapies-Drug by Regions 2011-2016
Figure United States Consumption Value Market Share of Stem cell based Cell therapies-Drug by Regions in 2014
Figure United States Consumption Value Market Share of Stem cell based Cell therapies-Drug by Regions in 2015
Table Consumption Price of Stem cell based Cell therapies-Drug by Regions 2011-2016 (USD/Unit)
Table United States and Major Manufacturers Capacity of Stem cell based Cell therapies-Drug 2011-2016 (Unit)
Table United States Capacity Market Share of Major Stem cell based Cell therapies-Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Stem cell based Cell therapies-Drug 2011-2016 (Unit)
Table United States Production Market Share of Major Stem cell based Cell therapies-Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Stem cell based Cell therapies-Drug 2011-2016 (Unit)
Table United States Sales Market Share of Major Stem cell based Cell therapies-Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Stem cell based Cell therapies-Drug 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Stem cell based Cell therapies-Drug Manufacturers 2011-2016
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Stem cell based Cell therapies-Drug 2011-2016
Figure United States Capacity Utilization Rate of Stem cell based Cell therapies-Drug 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Stem cell based Cell therapies-Drug 2011-2016
Figure United States Production Market Share of Major Stem cell based Cell therapies-Drug Manufacturers in 2014
Figure United States Production Market Share of Major Stem cell based Cell therapies-Drug Manufacturers in 2015
Figure United States Sales Market Share of Major Stem cell based Cell therapies-Drug Manufacturers in 2014
Figure United States Sales Market Share of Major Stem cell based Cell therapies-Drug Manufacturers in 2015
Figure United States Sales (Unit) and Growth Rate of Stem cell based Cell therapies-Drug 2011-2016
Table United States Supply, Consumption and Gap of Stem cell based Cell therapies-Drug 2011-2016 (Unit)
Table United States Import, Export and Consumption of Stem cell based Cell therapies-Drug 2011-2016 (Unit)
Table Price of United States Stem cell based Cell therapies-Drug Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of United States Stem cell based Cell therapies-Drug Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Stem cell based Cell therapies-Drug 2011-2016 (M USD)
Table United States Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Stem cell based Cell therapies-Drug 2011-2016
Table CESCA Therapeutics Inc Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Stem cell based Cell therapies-Drug Picture and Specifications of CESCA Therapeutics Inc
Table Stem cell based Cell therapies-Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of CESCA Therapeutics Inc 2011-2016
Figure Stem cell based Cell therapies-Drug Capacity (Unit), Production (Unit) and Growth Rate of CESCA Therapeutics Inc 2011-2016
Figure Stem cell based Cell therapies-Drug Production (Unit) and United States Market Share of CESCA Therapeutics Inc 2011-2016
Table CESCA Therapeutics Inc Stem cell based Cell therapies-Drug SWOT Analysis
Table OCAtA Therapeutics Inc Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Stem cell based Cell therapies-Drug Picture and Specifications of OCAtA Therapeutics Inc
Table Stem cell based Cell therapies-Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of OCAtA Therapeutics Inc 2011-2016
Figure Stem cell based Cell therapies-Drug Capacity (Unit), Production (Unit) and Growth Rate of OCAtA Therapeutics Inc 2011-2016
Figure Stem cell based Cell therapies-Drug Production (Unit) and United States Market Share of OCAtA Therapeutics Inc 2011-2016
Table OCAtA Therapeutics Inc Stem cell based Cell therapies-Drug SWOT Analysis
Table Orgenesis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Stem cell based Cell therapies-Drug Picture and Specifications of Orgenesis
Table Stem cell based Cell therapies-Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Orgenesis 2011-2016
Figure Stem cell based Cell therapies-Drug Capacity (Unit), Production (Unit) and Growth Rate of Orgenesis 2011-2016
Figure Stem cell based Cell therapies-Drug Production (Unit) and United States Market Share of Orgenesis 2011-2016
Table Orgenesis Stem cell based Cell therapies-Drug SWOT Analysis
Table TiGenix NV Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Stem cell based Cell therapies-Drug Picture and Specifications of TiGenix NV
Table Stem cell based Cell therapies-Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of TiGenix NV 2011-2016
Figure Stem cell based Cell therapies-Drug Capacity (Unit), Production (Unit) and Growth Rate of TiGenix NV 2011-2016
Figure Stem cell based Cell therapies-Drug Production (Unit) and United States Market Share of TiGenix NV 2011-2016
Table TiGenix NV Stem cell based Cell therapies-Drug SWOT Analysis
Table Mesobalst Ltd Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Stem cell based Cell therapies-Drug Picture and Specifications of Mesobalst Ltd
Table Stem cell based Cell therapies-Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Mesobalst Ltd 2011-2016
Figure Stem cell based Cell therapies-Drug Capacity (Unit), Production (Unit) and Growth Rate of Mesobalst Ltd 2011-2016
Figure Stem cell based Cell therapies-Drug Production (Unit) and United States Market Share of Mesobalst Ltd 2011-2016
Table Mesobalst Ltd Stem cell based Cell therapies-Drug SWOT Analysis
Table Pluristem Therapeutics Inc Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Stem cell based Cell therapies-Drug Picture and Specifications of Pluristem Therapeutics Inc
Table Stem cell based Cell therapies-Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pluristem Therapeutics Inc 2011-2016
Figure Stem cell based Cell therapies-Drug Capacity (Unit), Production (Unit) and Growth Rate of Pluristem Therapeutics Inc 2011-2016
Figure Stem cell based Cell therapies-Drug Production (Unit) and United States Market Share of Pluristem Therapeutics Inc 2011-2016
Table Pluristem Therapeutics Inc Stem cell based Cell therapies-Drug SWOT Analysis
Table Stem cell based Cell therapies-Drug Price by Regions 2011-2016
Table Stem cell based Cell therapies-Drug Price by Product Types 2011-2016
Table Stem cell based Cell therapies-Drug Price by Companies 2011-2016
Table Stem cell based Cell therapies-Drug Gross Margin by Companies 2011-2016
Table Price Comparison of Stem cell based Cell therapies-Drug by Regions 2011-2016 (USD/Unit)
Table Price of Different Stem cell based Cell therapies-Drug Product Types (USD/Unit)
Table Market Share of Different Stem cell based Cell therapies-Drug Price Level
Table Gross Margin of Different Stem cell based Cell therapies-Drug Applications
Table Marketing Channels Status of Stem cell based Cell therapies-Drug
Table Traders or Distributors of Stem cell based Cell therapies-Drug with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Stem cell based Cell therapies-Drug (USD/Unit) in 2015
Table United States Import, Export, and Trade of Stem cell based Cell therapies-Drug (Unit)
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Stem cell based Cell therapies-Drug 2016-2021
Figure United States Capacity Utilization Rate of Stem cell based Cell therapies-Drug 2016-2021
Table United States Stem cell based Cell therapies-Drug Production by Type 2016-2021 (Unit)
Table United States Stem cell based Cell therapies-Drug Production Market Share by Type 2016-2021
Figure United States Production Market Share of Stem cell based Cell therapies-Drug by Type in 2021
Figure United States Sales (Unit) and Growth Rate of Stem cell based Cell therapies-Drug 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Stem cell based Cell therapies-Drug 2016-2021
Figure United States Sales of Stem cell based Cell therapies-Drug by Applications 2016-2021 (Unit)
Table United States Production Market Share of Stem cell based Cell therapies-Drug by Applications 2016-2021
Figure United States Production Market Share of Stem cell based Cell therapies-Drug by Applications in 2021
Table United States Production, Import, Export and Consumption of Stem cell based Cell therapies-Drug 2016-2021 (Unit)
Table United States Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Stem cell based Cell therapies-Drug 2016-2021
Table Major Raw Materials Suppliers of Stem cell based Cell therapies-Drug with Contact Information
Table Manufacturing Equipment Suppliers of Stem cell based Cell therapies-Drug with Contact Information
Table Major Players of Stem cell based Cell therapies-Drug with Contact Information
Table Key Consumers of Stem cell based Cell therapies-Drug with Contact Information
Table Supply Chain Relationship Analysis of Stem cell based Cell therapies-Drug
Table New Project SWOT Analysis of Stem cell based Cell therapies-Drug
Table New Project Investment Feasibility Analysis of Stem cell based Cell therapies-Drug
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
